Answers are grounded in this paper and cite their sources.
The Transforming Growth Factor-beta (TGF-β) signaling pathway is a master regulator of cellular processes, including proliferation, differentiation and apoptosis, with profound implications for tissue homeostasis and disease pathogenesis. This review delves into the mechanisms and applications of TGF-β signaling within organoids, three-dimensional (3D) cultures that mimic human tissue architecture and function. We systematically explore the multifaceted role of TGF-β in organoid initiation, growth, and differentiation, highlighting its influence on stem cell self-renewal and lineage specification. The interplay between TGF-β and other signaling pathways, such as Wnt/β-catenin and Notch, is critical for maintaining tissue homeostasis and regulating stem cell niches. Furthermore, we discuss the significance of TGF-β signaling in modeling diseases like cancer and fibrosis, where its dysregulation is often implicated. Modulating TGF-β signaling in organoids holds vast therapeutic potential, offering insights into disease pathogenesis, predicting drug responses, and developing personalized treatment strategies. As our understanding of TGF-β signaling and organoid technology advances, these systems hold promise for groundbreaking biomedical research, potentially revolutionizing regenerative medicine and personalized therapeutics.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: